GRCE · Grace Therapeutics, Inc.
Market Cap
$44.18M
Shares
21.04M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-11 | 4,126 | $2.11 | $8,706 |
| 2026-08-07 | 299 | $2.12 | $634 |
| 2026-07-17 | 12,589 | $2.41 | $30,339 |
| 2026-06-23 | 1,054 | $2.26 | $2,382 |
| 2026-06-17 | 15,836 | $2.22 | $35,156 |
| 2026-06-16 | 16,995 | $2.21 | $37,559 |
| 2026-06-15 | 8,015 | $2.20 | $17,633 |
| 2026-06-12 | 84 | $2.30 | $193 |
| 2026-06-11 | 84 | $2.31 | $194 |
| 2026-06-09 | 1,426 | $2.30 | $3,280 |
Showing 1–10 of 10 settlements
Key facts
CIK
1444192
CUSIP
00439U104
13F (30d)
27 filings
27 filers
Visit website
Investor relations